asparaginase

Type: Keyphrase
Name: asparaginase
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2014 second quarter financial results on Tuesday, August 5, 2014, after the close of the financial markets. Company management will host a live audio webcast ... [Published TickerTech.com - Jul 22 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

MicroRNA-140-5p as a tumor suppressor and sensitizing agent for chemotherapy

The present invention provides a method of improving a therapeutic response to a cancer treatment, in a subject, the method comprising administering an effective amount of an agent that enhances the expression of microRNA-140-5p or an agent that mimics ... [Published PharmCast - Jul 18 2014]
First reported Jul 02 2014 - Updated Jul 03 2014 - 1 reports

Jazz Pharmaceuticals Announces Agreement To Acquire Rights To Defibrotide In The Americas From Sigma-Tau..

-- Jazz Pharmaceuticals to own worldwide rights to defibrotide at closing-- Investor conference call to be held today, July 2 at 8:30 AM EDT/1:30 PM IST As part of the agreement, Sigma-Tau would receive an upfront payment of $75 million"The acquisition ... [Published ADVFN UK - Jul 02 2014]
First reported Jul 01 2014 - Updated Jul 01 2014 - 1 reports

Batter Up!

While battered and breaded products historically have carried the onus of a bad rap nutritionally, new ingredients and processing strategies are helping to create better choices. This technology is allowing formulators to keep up with the nutrition demands ... [Published Prepared Foods - Jul 01 2014]
First reported Jun 27 2014 - Updated Jun 27 2014 - 1 reports

Paediatric haematological malignancies

This Update will discuss the epidemiology, key diagnostic features and current therapies of childhood leukaemia.Dr Pasquale Barbaro BMedSci, MBBS, FRACP, FRCPAHonorary Haematology Fellow,Children’s Hospital at Westmead, SydneyConflicts: nothing to de ... [Published Medical Observer - Jun 27 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Using MRD to Intensify Therapy in Patients With ALL

Children with acute lymphoblastic leukemia (ALL) who test positive for minimal residual disease (MRD) could benefit from stronger postremission therapy, but they might also experience more toxicity, according to the randomized controlled UKALL 2003 t ... [Published Diabetes Care - Jun 26 2014]
First reported May 20 2014 - Updated May 20 2014 - 1 reports

Research and Markets: Baking Enzymes Market 2014-2019: Types & Applications Trends & Forecasts

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8tqx89/baking_enzymes) has announced the addition of the "Baking Enzymes Market by Geography, Types & Application- Global Trends & Forecasts to 2019" report to their ... [Published Business Wire Retail News - May 20 2014]
First reported May 08 2014 - Updated May 08 2014 - 1 reports

Compositions and methods for delivering inhibitory oligonucleotides

The present invention features compositions and methods that make use of complexes comprising one or more inhibitory nucleic acids and a targeting polypeptide, wherein the targeting polypeptide consists of a cell surface receptor ligand. The compositions ... [Published PharmCast - May 08 2014]
First reported May 07 2014 - Updated May 07 2014 - 1 reports

Erytech receives ANSM authorisation to begin phase II study in pancreatic cancer

Erytech Pharma, a French bio-pharmaceutical company that develops innovative treatments for acute leukaemia and other oncology indications with unmet medical needs, announces that the French healthcare agency, ANSM has granted the authorisation to start ... [Published PharmaBiz - May 07 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

Tumor-initiating cells and methods of use

Provided herein are an isolated or enriched population of tumor initiating cells derived from normal cells, cells susceptible to neoplasia, or neoplastic cells. Methods of use of the cells for screening for anti-hyperproliferative agents, and use of the ... [Published PharmCast - Apr 09 2014]
First reported Mar 02 2014 - Updated Mar 02 2014 - 1 reports

Delivery system for cytotoxic drugs by bispecific antibody pretargeting

The present invention relates to methods and compositions for pretargeting delivery of therapeutic agents. In preferred embodiments, the pretargeting method comprises: a) administering a bispecific antibody with a first binding site for a disease-associated ... [Published PharmCast - Mar 02 2014]

Quotes

"This transaction would not only strengthen our global presence, but also demonstrate our commitment to diversify and expand our U S commercial portfolio with meaningful new therapies" said Russell Cox
...The researchers "showed that you can change treatment in a practical manner and improve outcomes."
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8tqx89/baking_enzymes) has announced the addition of the "Baking Enzymes Market by Geography, Types & Application- Global Trends & Forecasts to 2019" report to their offering. The global baking industry is fast inculcating the use of enzymes in light of the numerous advantages they present...
"The addition of ADX-N05 to our development pipeline is an excellent strategic fit for Jazz given our strong clinical expertise in sleep and narcolepsy" said Jeffrey Tobias

More Content

All (14) | News (12) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Jazz Pharmaceuticals to Report 2014 Second Quar... [Published TickerTech.com - Jul 22 2014]
MicroRNA-140-5p as a tumor suppressor and sensi... [Published PharmCast - Jul 18 2014]
Jazz Pharmaceuticals Announces Agreement To Acq... [Published ADVFN UK - Jul 02 2014]
Batter Up! [Published Prepared Foods - Jul 01 2014]
Paediatric haematological malignancies [Published Medical Observer - Jun 27 2014]
Using MRD to Intensify Therapy in Patients With... [Published Diabetes Care - Jun 26 2014]
Research and Markets: Baking Enzymes Market 201... [Published Business Wire Retail News - May 20 2014]
Compositions and methods for delivering inhibit... [Published PharmCast - May 08 2014]
Erytech receives ANSM authorisation to begin ph... [Published PharmaBiz - May 07 2014]
Tumor-initiating cells and methods of use [Published PharmCast - Apr 09 2014]
Delivery system for cytotoxic drugs by bispecif... [Published PharmCast - Mar 02 2014]
Jazz Pharmaceuticals Announces Acquisition From... [Published PR Newswire - Jan 13 2014]
Methods and compositions for targeting agents i... [Published PharmCast - Jan 05 2014]
NPPA revises prices of 63 more formulation pack... [Published PharmaBiz - Nov 09 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Research and Markets: Baking Enzymes Market 201... [Published Business Wire Retail News - May 20 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8tqx89/baking_enzymes) has announced the addition of the "Baking Enzymes Market by Geography, Types & Application- Global Trends & Forecasts to 2019" report to their ...
1

Press Releases

sort by: Date | Relevance
Jazz Pharmaceuticals Announces Acquisition From... [Published PR Newswire - Jan 13 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.